Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 0 results

Not applicableWithdrawnNCT05482542
What this trial is testing

Optimal Conditioning Regimen for Autologous Transplantation of Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Scripps Health
Post-approval studies (Phase 4)Study completedNCT04952766
What this trial is testing

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

Who this might be right for
Kidney TransplantMyelomaCancer+6 more
Centre Hospitalier Régional d'Orléans 196
Testing effectiveness (Phase 2)Ended earlyNCT04971005
What this trial is testing

Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled Trial

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Universitätsklinikum Hamburg-Eppendorf 1
Very early researchActive Not RecruitingNCT04096443
What this trial is testing

Oral FMT (Fecal Microbial Transplant) in Subjects with Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Griffin Hospital 9
Early research (Phase 1)Study completedNCT00014755
What this trial is testing

Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Fred Hutchinson Cancer Center 35
Not applicableUnknownNCT04674280
What this trial is testing

Observational Study in Multiple Sclerosis Patients Treated With Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Multiple Sclerosis
European Society for Blood and Marrow Transplantation 50
Early research (Phase 1)Ended earlyNCT03594487
What this trial is testing

Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Jeffrey Gelfand 5
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Emerging Indications for Hyperbaric Oxygen Treatment

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100